NFKB1 and neoplasm: For instance, inhibition of the NF-κB pathway greatly sensitizes glioblastoma cells to PDT-induced necrosis [38], and targeting the PI3K pathway with inhibitor LY294002 significantly enhances PDT outcomes in esophageal tumor cells and tumor model [138].